Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zimmermann

Showing results (161-170 of 279) with videos related to

Pageof 28
Sort By:
Haematologica|May 13, 2014
Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemiaDaria G Valerio, Jenny E Katsman-Kuipers, Joop H Jansen, et al.
Blood|October 16, 2004
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95Wilhelm Woessmann, Kathrin Seidemann, Georg Mann, et al.
Leukemia|December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.
Pediatric Blood & Cancer|September 21, 2022
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trialKerstin Mezger, Sabine Ebert, Hannah Elisa Muhle, et al.
Blood Advances|January 14, 2025
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALLTamara Kempter, Paulina Richter-Pechańska, Katarzyna Michel, et al.
Haematologica|October 26, 2010
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in childrenIlske Oschlies, Birgit Burkhardt, Itziar Salaverria, et al.
Haematologica|June 13, 2015
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemiaJasmijn D E de Rooij, Eva Beuling, Marry M van den Heuvel-Eibrink, et al.
Leukemia|September 29, 2023
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platformAmir Enshaei, Javier Martinez Elicegui, Esther Anguiano, et al.
Blood|May 25, 2013
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Blood Cancer Journal|April 2, 2026
Molecular variants, clonal evolution and clinical relevance in pediatric and adult T-cell lymphoblastic neoplasiaSarah Sandmann, Marcel Te Vrugt, Gerrit Randau, et al.
Pageof 28

Showing results (161-170 of 279) with videos related to

Sort By:
Pageof 28
Haematologica|May 13, 2014
Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemiaDaria G Valerio, Jenny E Katsman-Kuipers, Joop H Jansen, et al.
Blood|October 16, 2004
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95Wilhelm Woessmann, Kathrin Seidemann, Georg Mann, et al.
Leukemia|December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.
Pediatric Blood & Cancer|September 21, 2022
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trialKerstin Mezger, Sabine Ebert, Hannah Elisa Muhle, et al.
Blood Advances|January 14, 2025
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALLTamara Kempter, Paulina Richter-Pechańska, Katarzyna Michel, et al.
Haematologica|October 26, 2010
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in childrenIlske Oschlies, Birgit Burkhardt, Itziar Salaverria, et al.
Haematologica|June 13, 2015
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemiaJasmijn D E de Rooij, Eva Beuling, Marry M van den Heuvel-Eibrink, et al.
Leukemia|September 29, 2023
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platformAmir Enshaei, Javier Martinez Elicegui, Esther Anguiano, et al.
Blood|May 25, 2013
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Blood Cancer Journal|April 2, 2026
Molecular variants, clonal evolution and clinical relevance in pediatric and adult T-cell lymphoblastic neoplasiaSarah Sandmann, Marcel Te Vrugt, Gerrit Randau, et al.
Pageof 28